BillionToOne, Inc. (BLLN)

NMS – Цена в реальном времени. Валюта: USD

94.23

-11.71 (-11.05%)

При закрытии: May 12, 2026, 4:00 PM EDT

95.27

+1.04 (1.10%)

До открытия: May 13, 2026, 8:51 AM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

BillionToOne, Inc. (BLLN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

BillionToOne, Inc. (BLLN)

Wall Street Analysts Predict a 25.63% Upside in BillionToOne (BLLN): Here's What You Should Know

BillionToOne (BLLN) Reports Q1 Earnings: What Key Metrics Have to Say

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics

BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

BillionToOne, Inc. (BLLN) Q4 2025 Earnings Call Transcript

BillionToOne: Delivering And Lagging At The Same Time

Видео

No Data

Пресс-релизы

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics

BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance

Search stocks

BillionToOne, Inc. (BLLN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

BillionToOne, Inc. (BLLN)

Wall Street Analysts Predict a 25.63% Upside in BillionToOne (BLLN): Here's What You Should Know

BillionToOne (BLLN) Reports Q1 Earnings: What Key Metrics Have to Say

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics

BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

BillionToOne, Inc. (BLLN) Q4 2025 Earnings Call Transcript

BillionToOne: Delivering And Lagging At The Same Time

Видео

No Data

Пресс-релизы

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics

BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance